VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
NVIDIA Corporation vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
NVIDIA Corporation
NVDA · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into NVIDIA Corporation's moat claims, evidence, and risks.
View NVDA analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: NVIDIA Corporation leads (97 / 100 vs 74 / 100 for Sanofi).
- Segment focus: NVIDIA Corporation has 5 segments (88.3% in Data Center); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Quasi-Monopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: NVIDIA Corporation has 7 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
NVIDIA Corporation
Data Center
Data center accelerated computing (AI GPUs, systems, and networking)
Global
Hyperscale cloud providers, enterprises, public sector (often via OEMs/ODMs and integrators)
Fabless designer and platform supplier (chips, systems, software)
88.3%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
NVIDIA Corporation strengths
Sanofi strengths
Segment mix
NVIDIA Corporation segments
Full profile >Data Center
Quasi-Monopoly
Gaming
Duopoly
Professional Visualization
Oligopoly
Automotive
Competitive
OEM & Other
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.